Allogeneic hematopoietic cell transplantation and other expensive cellular therapies: a miracle for the few but off limits to many?

15 November 2019 - The number of patients undergoing allogeneic hematopoietic cell transplantation (HCT) for treatment of malignant and nonmalignant disorders ...

Read more →

Life saving therapy denied to dying cop

20 November 2019 - Doctors at Sydney’s Royal Prince Alfred Hospital are refusing to treat a terminally ill cancer ­patient ...

Read more →

Triumvira Immunologics announces fast track designation for its first TAC T-Cell therapeutic product candidate: TAC01-CD19

7 November 2019 - Designation confirms significant unmet need remains in DLBCL. ...

Read more →

Innovation and access at the mercy of payment policy: the future of chimeric antigen receptor therapies

1 November 2019 - In 2017, the US FDA approved the first chimeric antigen receptor therapies (CAR-Ts), tisagenlecleucel and axicabtagene ...

Read more →

FDA grants FX-322 fast track designation

10 October 2019 - The company also announced today that the U.S. FDA has granted fast track designation for FX-322.  ...

Read more →

Novartis completes certification of initial sites in Quebec for first approved Canadian CAR-T therapy, Kymriah (tisagenlecleucel)

9 October 2019 - Quebec government to reimburse Kymriah therapy for certain patients with life-threatening cancers who are in critical ...

Read more →

SanBio granted regenerative medicine advanced therapy designation from the U.S. FDA for SB623 for the treatment of chronic neurological motor deficits secondary to traumatic brain injury

19 September 2019 - The SanBio Group today announced that the U.S. FDA has granted regenerative medicine advanced therapy designation ...

Read more →

Immunotherapy a groundbreaking new cancer treatment, but prohibitively expensive

10 September 2019 - Dave Roberts is fighting for his life, and his doctor says there is only one option ...

Read more →

DiscGenics receives FDA fast track designation for disc degeneration cell therapy

26 August 2019 - DiscGenics today announced that the U.S. FDA has granted Fast Track designation for its investigational cell ...

Read more →

Cancer patient David Downs working to bring treatment that helped him to NZ

18 August 2019 - There are those people who cheerfully refer to themselves as glass half-full types – and then ...

Read more →

Trump Administration makes CAR T-Cell cancer therapy available to Medicare beneficiaries nationwide

7 August 2019 - Decision ensures consistency in access to the innovative new cancer therapy, and CMS is working closely ...

Read more →

ICER seeks public comment on proposed methods adaptations for assessments of potential cures and other transformative therapies

6 August 2019 - Proposed adaptations help manage increased uncertainty, capture new value dimensions for appraisal committee voting, and adopt a ...

Read more →

Melbourne to pioneer free treatment to save sickest cancer kids

4 August 2019 - The nation’s youngest cancer patients, who had previously been forced to travel overseas for lifesaving treatment, will ...

Read more →

Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments

30 July 2019 - Unusually high numbers of U.S. lymphoma patients are choosing experimental treatments over expensive cell therapies sold by ...

Read more →

CAR T-cell therapy: a microcosm for the challenges ahead in Medicare

29 July 2019 - The search for more effective and less toxic therapies for cancer has occupied scientists for decades. ...

Read more →